Arthritis Cure - New cell-based targets for treating autoimmune inflammatory diseases
New cell-based targets for treating autoimmune inflammatory diseases
EurekAlert! - Aug 30 9:21 PM
Patients with systemic autoimmune diseases such as lupus and rheumatoid arthritis (RA) often suffer loss of kidney function.Save to My Web
Staying fit after 60
The Fort Collins Coloradoan - 49 minutes ago
At an age when most people are beginning to savor their golden years, Bob Fulton keeps going for the gold.Save to My Web
Finding their niche: Tomah Wellness and Natural Connections
River Valley Business Report - Aug 30 8:00 PM
TOMAH, Wis. For Claire Morkin and Paula Caucutt, the location of their businesses makes clear sense. Morkin and Caucutt operate separate businesses in one building on 1012 Superior Ave. Morkin operates the Tomah Wellness Center. Caucutt operates Natural Connections.Save to My Web
Millennium Announces Phase I Trial Of MLN0415 For Inflammatory Disorders
Medical News Today - Aug 31 12:08 AM
Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced the initiation of a Phase I study of MLN0415, an oral, highly selective, small molecule inhibitor of IKK2, which targets a major inflammatory pathway. The randomized, double-blind, placebo-controlled study will enroll up to 72 healthy volunteers and assess safety, tolerability, pharmacokinetic and pharmacodynamic effects. [click link Save to My Web
Sports calendar listings
Poughkeepsie Journal - Aug 31 12:20 AM
The Sports Calendar is a public service of the Poughkeepsie Journal. Items should be mailed to Sports Calendar, Poughkeepsie Journal, P.O. Box 1231, Poughkeepsie, N.Y., 12602, faxed to 845-437-4879, or e-mailed to players@poughkeepsiejournal.com . All phone numbers are 845 area code unless otherwise listed.Save to My Web
Chemokine analogs granted US patent
PharmaBiz - 2 hours, 23 minutes ago
Chemokine Therapeutics Corp., a biotechnology company, announced that the US Patent and Trademark Office has issued US Patent 7,091,310 B2 relating to chemokine analogs for the treatment of human disease.Save to My Web
Pest Control Research Leads To Pain Control Discovery
BioresearchOnline - Aug 29 5:54 AM
A newly discovered enzyme inhibitor, identified by researchers originally looking for biological pest controls, may lead to pain relief for sufferers of arthritis and other inflammatory diseases, say researchers at the University of California, DavisSave to My Web

